Best Doctors for Thyroid Cancer Treatment in India

Thyroid cancer is the most treatable cancer in this directory, and the thing worth assessing is not who can do the biggest operation but who will recommend the right sized one.

1. Surgeon Volume Changes the Complication Rate

Thyroid surgery has two specific risks, and both are strongly influenced by how often the surgeon operates.

• The nerves controlling the voice run immediately behind the thyroid

• The parathyroid glands, which control calcium, sit on its surface and are easily damaged

Surgeons performing this operation frequently have lower rates of both complications. Ask how many thyroidectomies your surgeon performs each year, and what their own rate of permanent voice change and permanent calcium problems is.

2. Nuclear Medicine Facilities on Site

Where radioactive iodine is needed, it requires a licensed facility and usually an isolation period.

• Ask whether the hospital delivers it on site or refers elsewhere

• Ask what the isolation arrangements are and how long they last

• Ask what documentation you will receive for travel afterwards

That last point matters more for international patients than anyone tends to mention, and section 16 explains why.

3. Pathology That Guides the Right Operation

The extent of surgery should follow what the biopsy and imaging show, not a default. A centre that reports fine needle biopsy reliably and stages the neck properly is what allows a smaller operation to be offered safely.

4. Consultations in English

Clinical work at the major centres runs in English, so you can read your own pathology report and carry home a discharge summary your own doctor can act on. Interpreters for Arabic, French, Russian and Kiswahili are available at most of these hospitals.

5. Cost

Costs in India are generally lower than in Europe, North America or the Gulf, and thyroid cancer sits at the lower end of the oncology range because most patients need one operation rather than months of treatment.

Section 14 gives the figures.

1. First, the Reassurance

Most thyroid cancer has a good outlook, and that is worth saying before anything else because a cancer diagnosis rarely arrives with reassurance attached.

The commonest type grows slowly and is usually confined to the thyroid or nearby lymph nodes when found. Most patients are treated with surgery and go on to live normally, with the main ongoing requirement being a daily hormone tablet.

That does not make it trivial. It does mean the questions worth asking are different from those for other cancers, and section 5 sets out why.

2. Symptoms, and How It Is Usually Found

Thyroid cancer is often found incidentally, on a scan done for another reason, rather than because of symptoms.

Where symptoms occur:

• A lump in the front of the neck that can be felt or seen

• Hoarseness or a change in the voice that persists

• Difficulty swallowing, or a sensation of something in the throat

• Swollen lymph nodes in the neck

• Rarely, difficulty breathing

Most thyroid lumps are not cancer. A persistent lump should still be assessed, with an ultrasound and, where indicated, a fine needle biopsy.

A voice change alongside a neck lump warrants prompt assessment rather than watchful waiting.

3. The Four Types Behave Completely Differently

This determines everything else, so establish which you have.

• Papillary is by far the commonest. It grows slowly, often spreads to neck lymph nodes without that greatly affecting the outlook, and generally responds well to treatment.

• Follicular is less common, behaves similarly, and is more likely than papillary to spread through the bloodstream to lungs or bone.

• Medullary arises from different cells, does not respond to radioactive iodine, and may be inherited. Genetic testing is relevant here in a way it is not for the others.

• Anaplastic is rare and aggressive, needs urgent treatment, and is managed quite differently from the others.

Papillary and follicular together account for the large majority, and it is those two the reassuring picture in section 1 describes. If you have medullary or anaplastic disease, much of what is written about thyroid cancer generally does not apply to you.

For the pathway across all types, see how thyroid cancer is treated.

4. Diagnosis

• Ultrasound of the neck, assessing the nodule and the lymph nodes

• Fine needle biopsy, taking cells from the nodule with a thin needle, usually under ultrasound guidance

• Blood tests of thyroid function, and a specific marker where medullary cancer is suspected

• Genetic testing, relevant for medullary cancer and its inherited form

• CT or MRI, where the disease appears more extensive

• Radioactive iodine scan, in defined situations rather than routinely

Fine needle biopsy results are sometimes indeterminate, meaning neither clearly benign nor clearly malignant. If yours was, ask what the plan is, because that situation has its own pathway rather than defaulting to surgery.

5. The Question Most Patients Are Not Asked: How Much Surgery

This is the most important section on the page.

For decades total thyroidectomy, removing the whole gland, was the standard operation for almost all thyroid cancer. That has changed. For many low-risk cancers, removing only the affected half is now considered appropriate, and guidelines have moved in that direction.

The difference matters permanently:

• Lobectomy removes half the gland. Many patients retain enough function to avoid lifelong hormone tablets, and the risks to voice nerves and parathyroid glands apply to one side only.

• Total thyroidectomy removes the whole gland. It commits you to a daily hormone tablet for life, and it doubles the anatomy at risk during surgery.

Total thyroidectomy is still the right operation for many patients, including those with larger tumours, extensive node involvement, certain types, or where radioactive iodine will be needed.

Ask directly: why this operation rather than the smaller one? A good surgeon will have a clear answer specific to your tumour. If the answer is that this is what they always do, seek a second opinion.

For selected very small papillary cancers, active surveillance rather than immediate surgery is also a recognised option at experienced centres. It is not right for everyone and it is not widely offered, but it is worth knowing it exists.

6. Surgical Options

• Lobectomy removes one lobe, for low-risk cancers confined to that side

• Total thyroidectomy removes the whole gland

• Central neck dissection removes lymph nodes immediately around the thyroid, where they are involved

• Lateral neck dissection removes nodes from the side of the neck, where imaging or biopsy shows involvement

• Completion thyroidectomy removes the remaining half in a second operation, where pathology after lobectomy shows more extensive disease than expected

Hospital stay is commonly three to five days, and recovery to normal activity often takes one to two weeks.

Ask specifically what will be done about the lymph nodes and on what evidence, since removing nodes that are not involved adds risk without benefit.

7. The Two Risks Worth Understanding

Both are uncommon in experienced hands and both are permanent when they occur, which is why surgeon volume matters.

Voice change. The nerves supplying the vocal cords run immediately behind the thyroid. Temporary hoarseness after surgery is common and usually settles. Permanent voice change is uncommon but does happen, and it matters disproportionately for anyone whose work depends on their voice.

Calcium problems. The parathyroid glands sit on the thyroid surface and control calcium. Temporary low calcium after total thyroidectomy is common and treated with supplements. Permanent damage, requiring lifelong calcium and vitamin D, is uncommon but possible.

Ask your surgeon for their own rates of both, and ask whether they monitor the nerves during surgery. These questions are reasonable and a high-volume surgeon will not be offended by them.

8. Radioactive Iodine Is Not for Everyone

The second place where less can be more.

Radioactive iodine is taken as a capsule or drink, absorbed by thyroid tissue, and used to destroy any remaining thyroid cells after surgery. It works only for papillary and follicular cancer, not for medullary or anaplastic.

For years it was given to nearly everyone after total thyroidectomy. Guidance has moved away from that:

• For low-risk cancers, it is often not recommended at all

• For intermediate-risk disease, it is a judgement call

• For higher-risk disease, it is standard

It is not without cost to the patient. It requires preparation, usually an isolation period, and it carries its own side effects and long-term considerations.

If radioactive iodine has been recommended, ask what risk category you are in and why it applies to you. Several published cost pages present it as a routine part of thyroid cancer treatment. For many patients it is not.

9. Life After Total Thyroidectomy

Where the whole gland is removed, you will take a thyroid hormone tablet every day for the rest of your life. This is not optional and it is not temporary.

• The tablet is inexpensive, quoted at a very low monthly cost in India

• The dose needs adjusting, guided by blood tests, particularly in the first year

• In thyroid cancer the dose is sometimes set deliberately higher than simple replacement, to suppress the hormone that stimulates thyroid tissue

• You need a reliable supply and reliable testing wherever you live

That last point deserves thought before you travel for treatment. Ask what dose you will go home on, how often blood tests are needed, and whether the same preparation is available in your country.

10. Other Treatments

External Beam Radiation

• When it is used: where surgery cannot remove everything, or for types that do not take up iodine

• How it is given: daily sessions over several weeks

• Who it applies to: a minority of thyroid cancer patients

Targeted Therapy

• What it is: treatment directed at specific molecular changes driving the cancer

• When it is used: advanced disease that no longer responds to iodine, and selected medullary cancers

• How it is given: usually as tablets over an extended period

Chemotherapy

• The honest position: conventional chemotherapy has a limited role in thyroid cancer

• When it is used: mainly for anaplastic disease

Several cost pages list chemotherapy among standard thyroid cancer treatments. For the great majority of patients it is not part of the plan.

11. Medullary Thyroid Cancer and Your Family

This type deserves separate treatment because the implications extend beyond the patient.

Medullary thyroid cancer arises from different cells and can be inherited, associated with changes in a specific gene. Where an inherited change is present:

• Relatives can be tested and, where positive, offered surveillance or preventive surgery

• Other glands may be affected, so screening for associated conditions is part of the assessment

• Radioactive iodine does not work for this type, so treatment relies on surgery and, in advanced cases, targeted therapy

• A blood marker is used for monitoring rather than the marker used in other thyroid cancers

If you have been diagnosed with medullary thyroid cancer, ask whether genetic testing has been done and whether genetic counselling is available. A positive result changes what your children and siblings should do.

12. Who Is on the Team

• Endocrinologist. Often the first specialist, arranging the ultrasound and biopsy and managing hormone treatment afterwards.

• Radiologist. Performs the ultrasound-guided biopsy and assesses the neck.

• Pathologist. Reports the type, which determines the entire plan.

• Endocrine, head and neck, or surgical oncology surgeon. Performs the operation. Compare specialists in our surgical oncology directory.

• Nuclear medicine physician. Delivers and supervises radioactive iodine where it is needed.

• Medical oncologist. Involved in advanced disease requiring targeted therapy. See medical oncologists across India.

• Radiation oncologist. Involved in the minority of cases where external radiation applies. See radiation oncologists in India.

For most patients the surgeon and the endocrinologist are the two who matter over the long term.

13. Records to Bring or Send

• Neck ultrasound report, with images, since this drives the surgical plan

• Fine needle biopsy result, in full rather than summarised

• Thyroid function blood results

• Where medullary cancer is suspected or confirmed, the relevant marker and any genetic testing

• CT or MRI where performed

• Where surgery has already been done, the operation note and full pathology, including what was removed and node findings

• Current medicine list, particularly any thyroid hormone dose

• Family history of thyroid or endocrine disease

The biopsy result matters most. If it was indeterminate rather than clearly malignant, say so when you send it, because that changes the conversation entirely.

14. Published Costs

Indicative published ranges, checked August 2026, in US dollars. Not quotes.

Overall course. Published totals sit at the lower end of the oncology range:

• About 1,880 to 3,350 in one source

• About 3,000 to 9,500 in another

• Rupee ranges elsewhere equivalent to roughly 2,400 to 12,000, with the upper figures covering advanced disease with multiple treatments

Individual components:

• Total thyroidectomy: roughly 2,400 to 4,800

• Robotic assistance, where offered: adds roughly 600 to 1,200

• Radioactive iodine: roughly 600 to 1,750 per session in most sources, with one source quoting higher. Most patients who need it require one to three sessions.

• External beam radiation: roughly 1,200 to 3,600 for a course of twenty-five to thirty sessions

• Targeted therapy: roughly 3,500 to 4,500 where it applies

• Diagnostics: roughly 120 to 300 for ultrasound, biopsy, scans and blood panels

• Hormone replacement: quoted at roughly 12 to 24 dollars per month, continuing for life after total thyroidectomy

• Post-surgery medication and stay: roughly 60 to 180

Three things worth noting.

This is the least expensive cancer in this directory to treat, because most patients need one operation and follow-up rather than months of systemic therapy. That is a function of the disease rather than of Indian pricing.

Basic packages often exclude diagnostics and follow-up. One source states plainly that pre-treatment imaging, biopsy and blood tests, and post-treatment hormone replacement and periodic scans, are usually billed separately. Ask what is inside the quoted figure.

The cheapest line is the one that never stops. Hormone replacement is a few dollars a month and continues for the rest of your life, alongside periodic blood tests. Over decades that is a real commitment, and it is a reason the lobectomy question in section 5 matters.

Confirm any figure in writing, and ask for the estimate itemised.

15. What an Estimate Should Cover

• Ultrasound, fine needle biopsy and blood tests, which are often billed separately

• The specific operation quoted, and whether lobectomy or total thyroidectomy

• Neck dissection, if lymph nodes are to be removed

• Completion thyroidectomy, if pathology after lobectomy calls for a second operation

• Radioactive iodine, stated per session with the expected number of sessions

• Isolation facility charges during radioactive iodine

• Calcium and vitamin D treatment, if parathyroid function is affected

• Hormone replacement and the blood tests to adjust it

• Follow-up scans and reviews after you return home

Ask about completion thyroidectomy specifically. If you are having a lobectomy, there is a defined chance that pathology will call for the other half to be removed, and knowing the cost in advance is better than discovering it.

16. Radioactive Iodine and International Travel

This is a practical matter that almost nothing published covers, and it affects anyone travelling home after treatment.

After radioactive iodine you remain mildly radioactive for a period. That has three consequences:

• An isolation period, usually in hospital, with restrictions on close contact afterwards for a defined time

• Restrictions on contact with children and pregnant women for a period after discharge

• Radiation detectors at airports and borders may be triggered for weeks afterwards, even when you are entirely safe

Ask the nuclear medicine department for a letter stating the treatment, the date, the dose and the expected duration of detectability, in English, on hospital letterhead. Carry it with you.

This is routine to request and easily forgotten. Being stopped at a border without documentation is avoidable and unpleasant.

Also ask when it is safe to fly and how long the contact restrictions last, particularly if you are travelling with young children.

17. Follow-up

Follow-up after thyroid cancer continues for years, and it is usually light rather than burdensome.

• Blood tests, checking hormone levels and a cancer marker used for monitoring

• Neck ultrasound at intervals

• Dose adjustment of hormone replacement, particularly in the first year

• Further scans, only where indicated rather than routinely

Before you leave the country, collect the operation note, the full pathology report stating the type and what was removed, the radioactive iodine record with the dose if given, your current hormone dose, and a written follow-up schedule.

Ask whether the Indian team will review blood results and scan reports sent from home. For thyroid cancer this is more practical than for most cancers, because monitoring is largely blood tests and ultrasound.

18. Looking Wider

For the treatment pathway across thyroid cancer, see how thyroid cancer is treated in India.

To compare specialists by discipline, see surgical oncologists in India, medical oncologists and radiation oncologists.

To discuss your own reports, send them to us on WhatsApp at wa.me/919044346292 or by email at care@gaf.healthcare.

Medical Review

Clinical review: required before publication by an endocrine surgeon, head and neck surgeon, or endocrinologist with thyroid cancer experience. The radioactive iodine sections would benefit from a nuclear medicine reviewer.

Medical content review: Dr. Shabnam, BDS, five years in medical content writing and review. Editorial review of medical content, not specialist clinical review.

Editorial review: Abdul Azeem, MA (Public Health specialisation).

Prepared with reference to published endocrine and oncology guidance and peer-reviewed literature on thyroid cancer management.